DJIA 18,285.74 0.34 0.00%
NASDAQ 5,090.79 19.05 0.38%
S&P 500 2,130.82 4.97 0.23%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.17 -0.39 (-0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $67.17 -0.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.40
Previous Close $67.56
Daily Range $66.55 - $68.48
52-Week Range $23.13 - $77.80
Market Cap $8.0B
P/E Ratio -337.80
Dividend (Yield) $0.00 (0.0%)
Volume 1,933,217
Average Daily Volume 2,378,153
Current FY EPS -$0.37




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

IWM, VGLT: Big ETF Inflows

Just What Is Invested Capital Anyway?


4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development

Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

Isis Pharmaceuticals' Q1 Loss Narrower than Expected - Analyst Blog

Isis Pharmaceuticals (ISIS) Earnings Report: Q1 2015 Conference Call Transcript

See More ISIS News...

ISIS's Top Competitors

ISIS $67.17 (-0.58%)
Current stock: ISIS
AMGN $163.84 (-0.09%)
Current stock: AMGN
CELG $116.20 (-0.56%)
Current stock: CELG
GILD $111.22 (0.95%)
Current stock: GILD